Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 39,333 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

39,333 Papers indexed
1,440 Papers AI scored
39,333 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.

LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

39333 results
C
Evaluation of the Cancer Awareness Measure in Adolescents in Turkiye: A Methodological Study.
PMID 38804151 Published: 2024-05-28 Ingested: 2026-08-02 12:03 AM Journal of adolescent and young adult oncology
AI -
Standard 61.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 61.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 20.0; sample size: 70.0; recency: 80.0; abstract quality: 85.0.

C
Associations and attributable burden between risk factors and all-cause and cause-specific mortality at different ages in patients with hypertension.
PMID 38783145 Published: 2024-05-23 Ingested: 2026-08-02 12:02 AM Hypertension research : official journal of the Japanese Society of Hypertension
AI -
Standard 61.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 61.0/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 80.0; abstract quality: 100.0.

AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 61.0/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 80.0; abstract quality: 100.0.

C
Outcome of 3q26.2/MECOM rearrangements in chronic myeloid leukemia.
PMID 38748089 Published: 2024-05-15 Ingested: 2026-08-02 12:02 AM International journal of hematology
AI -
Standard 61.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 61.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 30.0; sample size: 50.0; recency: 80.0; abstract quality: 85.0.

C
Same-Day Discharge for Pediatric Hemithyroidectomy Patients: Evaluating Safety and Barriers to Discharge.
PMID 38494856 Published: 2024-03-17 Ingested: 2026-08-02 12:02 AM Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
AI -
Standard 61.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 61.0/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 80.0; abstract quality: 100.0.

C
AI -
Standard 61.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 61.0/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 80.0; abstract quality: 100.0.

C
AI -
Standard 61.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 61.0/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 80.0; abstract quality: 100.0.

C
The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Expanded Database to Inform Revisions in the Ninth Edition of the TNM Classification of Pleural Mesothelioma.
PMID 38309456 Published: 2024-02-01 Ingested: 2026-08-02 12:02 AM Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
AI -
Standard 61.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 61.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 90.0; recency: 80.0; abstract quality: 85.0.

C
AI -
Standard 61.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 61.0/100. Study design: 60.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 60.0; recency: 80.0; abstract quality: 100.0.

AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 61.0/100. Study design: 70.0; human relevance: 90.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 80.0; abstract quality: 100.0.

C
AI -
Standard 61.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 61.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 90.0; recency: 65.0; abstract quality: 100.0.

Previous
Page 1680 of 3278
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic